BioElectronics Engages Dr. Christine Dumas as Spokesperson and Patient Advocate

  • July 17th, 2013
  • News
  • 0 Comments
  • bfichter

Health Care Advocate and Reporter Will Develop Public and Medical Education and Awareness Program FREDERICK, MD.  July 17, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has engaged Dr. Christine Dumas as public affairs spokesperson and patient advocate. “We’ve engaged the well-known health care advocate, Dr. Christine Dumas, to develop programs to increase awareness of BioElectronics drug-free treatments for pain,” […]

BioElectronics Announces Leading Medical Centers Launch Clinical Trials of ActiPatch® Therapy for Treating Pain and Reducing Drug Use

  • June 24th, 2013
  • News
  • 0 Comments
  • bfichter

Trials of ActiPatch® Use For Osteoarthritis in Knees, Pain Control in Hernia Surgery and Lower Back Pain Relief Are Underway FREDERICK, MD.  June 24, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, today announced that three clinical trials at leading medical centers around the world have ethics approval and […]

BioElectronics Unveils Fourth Generation Family of Drug-Free Pain Relievers

  • June 19th, 2013
  • News
  • 0 Comments
  • bfichter

New, Lighter and Water Resistant Products Optimized for Retail Marketplace FREDERICK, MD.  June 19, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, today announced its fourth generation of drug-free, anti-inflammatory medical devices.  The company said the new products are lighter and more shock and water resistant. “We designed this […]

BioElectronics Continues FDA Clearance Campaign to Bring Chronic Pain Sufferers Safe, Effective, Inexpensive, Drug-Free Pain Therapy

  • June 11th, 2013
  • News
  • 0 Comments
  • bfichter

FREDERICK, Md., June 10, 2013 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, which has sold 500,000 devices, without prescriptions, in 57 countries reported that they have received three letters from the Office of Science Integrity.  These letters are virtually identical in denying the firm’s request for the FDA Commissioner […]

BioElectronics Receives Working Capital Infusion

  • May 29th, 2013
  • News
  • 0 Comments
  • bfichter

Ex-Im Bank Provides Export Financing Support FREDERICK, Md., May 29, 2013 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, is pleased to announce it has been issued a $500,000 Line of Credit from Ex-Im Bank to create jobs and assist with export working capital. The funding will enable BioElectronics to […]

BioElectronics and Pulsed Shortwave Therapy Make Progress

  • May 23rd, 2013
  • News
  • 2 Comments
  • bfichter

Public Advisory Panel Accepts FDA’s Class II Re-Classification Suggestion FREDERICK, Md., May 23, 2013 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of very effective, safe consumer medical devices, comments on the FDA panel meeting for non-thermal shortwave diathermy: The FDA’s Public Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting was held on May 21, […]

BioElectronics Presents FDA Reclassification Panel

  • May 21st, 2013
  • News
  • 1 Comment
  • bfichter

Confirmation of Physiological Mechanism for Pain Relief FREDERICK, MD — 5/21/2013 — BioElectronics Corp. (OTC Pink: BIEL), the maker of inexpensive, disposable drug-free consumer electronic devices, announced that CEO, Andrew J. Whelan is presenting today to the FDA’s Medical Advisory Committee, Orthopedic and Rehabilitation Panel compelling arguments for reclassifying the company’s products for over the […]

BioElectronics New Patent Published

  • May 7th, 2013
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD, May 7, 2013 /PRNewswire/ — BioElectronics Corporation (OTC PINK: BIEL), maker of consumer medical electronics, announced today that the World Intellectual Property Organization, International Bureau has published its new patent (#WO2013059804) “Pulsed Electromagnetic Field Device with Adhesive Applicator”. The new patent combines Pulsed Electromagnetic Field (PEMF) Technology with the combining of an adhesive […]

BioElectronics to Ease Pain in Iraq

  • May 2nd, 2013
  • News
  • 0 Comments
  • bfichter

FREDERICK, Md., May 2, 2013 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of unique, safe, inexpensive, patented, pain products announced today that it has established distribution in Iraq with Mazaya Scientific Bureau for its ActiPatch® musculoskeletal therapy, Allay™ menstrual pain, and RecoveryRx™ post-operative and chronic wound products. Mazaya Scientific Bureau (www.mazaya-sb.com) is a leading […]

BioElectronics Has Expanded Distribution of ActiPatch and Allay Pain Products to Peru

  • April 11th, 2013
  • News
  • 0 Comments
  • bfichter

FREDERICK, Md., April 11, 2013 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of unique, safe, inexpensive over-the-counter pulsed shortwave therapy, announced today that it has established distribution in Peru of its ActiPatch Therapy, treatment of back, knee, elbow and other pain and musculoskeletal issues, and its Allay menstrual cycle pain therapy. Sistemas Analiticos […]